Regulatory News
Wednesday, January 11, 2017
UPDATE 1-Merck steals march on rivals in lung cancer drug combo race
* Move may put Merck ahead of AstraZeneca, Roche and Bristol
(Adds more reaction, latest shares, market background)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment